Mutations in the NOD1/2 signaling pathway and in DNA binding transcription factor activity, affecting genes such as MAP3K7, UBE2N, IKBKG, CHUK, and IKBKB, occurred late in breast adenocarcinoma and ovarian adenocarcinoma (Fig. S7–8). Here, NOD1 is linked to ovarian adenocarcinoma.